SCULPTRA
Report
- Report Number
- 3002807108-2009-00783
- Date Received
- December 21, 2009
- Report Date
- March 9, 2009
- Manufacturer
- GLOBAL PHARMACOVIGILANCE AND EPIDEMIOLOGY/SANOFI-AVENTIS
- Product Code
- LMH
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- NO INFORMATION
Narratives
A PTC (PHARMACEUTICAL TECHNICAL COMPLAINT) WAS INITIATED: (B)(4). IT REVEALED: BRR (BATCH RECORD REVIEW) WITHOUT HINT TO ROOT CAUSE. NO FAULTS, DEFECTS, DAMAGES DETECTABLE. SINCE NO LOT NUMBER IS AVAILABLE, AN INVESTIGATION HAS BEEN PERFORMED ON THE DOCUMENTATION OF ALL POTENTIALLY INVOLVED MANUFACTURED BATCHES MARKETED IN THE (B)(6). THE REVIEW OF THE DHR (DEVICE HISTORY RECORDS) AND OF THE ANALYTICAL RESULTS OF THESE BATCHES DIDN'T SHOW ANY ANOMALY THAT COULD BE RELATED TO THE EVENT OCCURRED. THE INVESTIGATION RESULTS SHOW THAT THIS KIND OF EVENT ISN'T BATCH RELATED. CONCLUSION: NO FAULTS DETECTABLE. REPORTER'S CAUSALITY ASSESSMENT: NOT PROVIDED.
(B)(4). INITIAL REPORT: THIS NON-SERIOUS SPONTANEOUS CASE REPORT FROM (B)(6) WAS REPORTED BY A NURSE VIA A COMPANY REPRESENTATIVE AND FORWARDED BY OUR LOCAL AFFILIATE (B)(4). INITIAL AND FOLLOW-UP INFORMATION RECEIVED ON 09-MAR AND 16-MAR-09 RESPECTIVELY WERE PROCESSED TOGETHER. THIS CASE INVOLVES A FEMALE PATIENT (AGE NOS) WHO RECEIVED POLY-L-LACTIC ACID (SCULPTRA) THERAPY SOMETIME IN 2008. RELEVANT MEDICAL HISTORY AND CONCOMITANT MEDICATION INFORMATION WERE NOT MENTIONED. ON AN UNKNOWN DATE THE PATIENT DEVELOPED VISIBLE LUMPS IN HER CHEEKS. THE PATIENT SAW A PLASTIC SURGEON WHO HAS INJECTED HYDROLASE INTO HER CHEEK. THE PATIENT HAS ALSO TRIED LASER TREATMENT ON HER SKIN TO SMOOTH IT OUT. EVENT OUTCOME IS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SCULPTRA | WRINKLE FILLER | LMH | GLOBAL PHARMACOVIGILANCE AND EPIDEMIOLOGY/SANOFI-AVENTIS | NA | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK |